186 related articles for article (PubMed ID: 22545131)
1. TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression.
Lee MS; Jung JI; Kwon SH; Lee SM; Morita K; Her S
PLoS One; 2012; 7(4):e35710. PubMed ID: 22545131
[TBL] [Abstract][Full Text] [Related]
2. A biologically active angiogenesis inhibitor, human serum albumin-TIMP-2 fusion protein, secreted from Saccharomyces cerevisiae.
Kang WK; Park EK; Lee HS; Park BY; Chang JY; Kim MY; Kang HA; Kim JY
Protein Expr Purif; 2007 Jun; 53(2):331-8. PubMed ID: 17368046
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biodistribution of human serum albumin-TIMP-2 fusion protein using near-infrared optical imaging.
Lee MS; Kim YH; Kim YJ; Kwon SH; Bang JK; Lee SM; Song YS; Hahm DH; Shim I; Han D; Her S
J Pharm Pharm Sci; 2011; 14(3):368-77. PubMed ID: 21962154
[TBL] [Abstract][Full Text] [Related]
4. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
5. Role of RUNX3 in suppressing metastasis and angiogenesis of human prostate cancer.
Chen F; Wang M; Bai J; Liu Q; Xi Y; Li W; Zheng J
PLoS One; 2014; 9(1):e86917. PubMed ID: 24475196
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
Dong Z; Nemeth JA; Cher ML; Palmer KC; Bright RC; Fridman R
Int J Cancer; 2001 Aug; 93(4):507-15. PubMed ID: 11477554
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Treponema pallidum protein Tp47 induces angiogenesis by modulating the matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in endothelial cells.
Gao ZX; Luo X; Liu LL; Lin LR; Tong ML; Yang TC
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1958-1970. PubMed ID: 31166625
[TBL] [Abstract][Full Text] [Related]
8. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
10. The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
Bratland A; Ragnhildstveit E; Bjørnland K; Andersen K; Maelandsmo GM; Fodstad O; Saatcioglu F; Ree AH
Clin Exp Metastasis; 2003; 20(6):541-7. PubMed ID: 14598888
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
12. [Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
Solov'eva NI; Timoshenko OS; Kugaevskaia EV; Andreeva IuIu; Zavalishina LE
Bioorg Khim; 2014; 40(6):743-51. PubMed ID: 25895371
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
Chetty C; Lakka SS; Bhoopathi P; Kunigal S; Geiss R; Rao JS
Cancer Res; 2008 Jun; 68(12):4736-45. PubMed ID: 18559520
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
[TBL] [Abstract][Full Text] [Related]
15. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
16. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
17. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-κB system.
Yang B; Zhang D; Qian J; Cheng Y
Mol Cell Biochem; 2020 Nov; 474(1-2):199-208. PubMed ID: 32737771
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion.
Myoung H; Hong SP; Yun PY; Lee JH; Kim MJ
Cancer Sci; 2003 Feb; 94(2):215-20. PubMed ID: 12708500
[TBL] [Abstract][Full Text] [Related]
19. TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.
Givvimani S; Kundu S; Narayanan N; Armaghan F; Qipshidze N; Pushpakumar S; Vacek TP; Tyagi SC
Arch Physiol Biochem; 2013 May; 119(2):65-74. PubMed ID: 23398532
[TBL] [Abstract][Full Text] [Related]
20. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
